Coca-Cola leans into protein, ‘zeros and diets’ as GLP-1 users reshape beverage habits

21 Oct 2025

Coca-Cola Co. executives appear unperturbed by a drop in consumption of full-sugar soft drinks by the rising number of consumers on appetite-suppressing GLP-1 drugs – choosing instead to lean into accelerating sales of low- and no-calorie options and high-protein beverages with stepped-up marketing and production.

Read full article at Beverage Daily